FOLH1 and prostate cancer: PSMA is a glycosylated type II transmembrane protein that is overexpressed in >90% of all primary prostate cancer lesions, tumor-positive lymph nodes, and metastases47, , –51 and is the most well established, highly specific prostate epithelial cell membrane antigen.52